Resources

Filter by:

Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers

Wheeler AP, Lim MY, Huguelet PS, Jaffray J, Staber JM, Funkhouser K, Carpenter SL, and Weyand AC
Bleeding Disorders LAN Developed WGBD Clinics (LAN)

Initial von Willebrand factor antigen values in adolescent females predict future values

Cohen CT, Zobeck M, Powers JM.
Von Willebrand Disease

Hemostatic considerations for gender affirming care

Garland, K, Mullins, E, Bercovitz, RS, Rodriguez, V, Connors, J, and Sokkary, N
LAN Developed Transgender Care

Multidisciplinary care of the pregnant patient with or at risk for venous thromboembolism: a recommended toolkit from the Foundation for Women and Girls with Blood Disorders Thrombosis Subcommittee

Samuelson Bannow B, Federspiel JJ, Abel DE, Mauney L, Rosovsky RP, Bates SM.
Guidelines LAN Developed Pregnancy and Postpartum

Recombinant von Willebrand factor and tranexamic acid for heavy menstrual bleeding in patients with mild and moderate von Willebrand disease in the USA (VWDMin): a phase 3, open-label, randomised, crossover trial

Ragni MV, Rothenberger SD, Feldman R, Nance D, Leavitt AD, Malec L, Kulkarni R, Sidonio R Jr, Kraut E, Lasky J, Pruthi R, Angelini D, Philipp C, Hwang N, Wheeler AP, Seaman C, Machin N, Xavier F, Meyer M, Bellissimo D, Humphreys G, Smith KJ, Merricks EP, Nichols TC, Ivanco D, Vehec D, Koerbel G, Althouse AD.
Heavy menstrual bleeding Von Willebrand Disease

Menstrual Technology Innovations and the Implications for Heavy Menstrual Bleeding

Liberty, A., Samuelson Bannow, B., Matteson, K., Edelman, A., & Colwill, A.
Heavy menstrual bleeding